This statistic depicts the share of adalimumab sales attributable to Humira compared to its biosimilars, as of August 2024. At this point, Humira held 73 percent of the adalimumab market in the United States.
Adalimumab market share of Humira and its U.S. biosimilar competitors as of August 2024
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Samsung Bioepis. (October 10, 2024). Adalimumab market share of Humira and its U.S. biosimilar competitors as of August 2024 [Graph]. In Statista. Retrieved January 06, 2025, from https://www.statista.com/statistics/1538532/humira-vs-biosimilars-market-share-in-the-us/
Samsung Bioepis. "Adalimumab market share of Humira and its U.S. biosimilar competitors as of August 2024." Chart. October 10, 2024. Statista. Accessed January 06, 2025. https://www.statista.com/statistics/1538532/humira-vs-biosimilars-market-share-in-the-us/
Samsung Bioepis. (2024). Adalimumab market share of Humira and its U.S. biosimilar competitors as of August 2024. Statista. Statista Inc.. Accessed: January 06, 2025. https://www.statista.com/statistics/1538532/humira-vs-biosimilars-market-share-in-the-us/
Samsung Bioepis. "Adalimumab Market Share of Humira and Its U.S. Biosimilar Competitors as of August 2024." Statista, Statista Inc., 10 Oct 2024, https://www.statista.com/statistics/1538532/humira-vs-biosimilars-market-share-in-the-us/
Samsung Bioepis, Adalimumab market share of Humira and its U.S. biosimilar competitors as of August 2024 Statista, https://www.statista.com/statistics/1538532/humira-vs-biosimilars-market-share-in-the-us/ (last visited January 06, 2025)
Adalimumab market share of Humira and its U.S. biosimilar competitors as of August 2024 [Graph], Samsung Bioepis, October 10, 2024. [Online]. Available: https://www.statista.com/statistics/1538532/humira-vs-biosimilars-market-share-in-the-us/
